Botulism future or investigational therapies

Botulism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Botulism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Botulism future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Botulism future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Botulism future or investigational therapies
CDC on Botulism future or investigational therapies
Botulism future or investigational therapies in the news
Blogs on Botulism future or investigational therapies
Directions to Hospitals Treating Botulism
Risk calculators and risk factors for Botulism future or investigational therapies

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

Classically, the treatment for botulism has been to deliver an antitoxin to the patient once exposed. Also, putting the patient on a mechanical ventilator has been a successful treatment method because patients with botulism have extreme trouble breathing on their own. Even though these treatments have been successful, there have been tests on a new drug that will block Potassium channels in order to restore neuromuscular function after botulinum intoxication.